WEREWOLF THERAPEUTICS INC (HOWL)
US95075A1079 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 16.4M | 19.943M 21.60% | 1.917M -90.39% | 2.572M 34.17% | 10.2M 296.58% | 6.202M -39.20% | 39.143M 531.14% | 118.12M 201.77% | 229.17M 94.01% | 211.36M -7.77% | ||
| EBITDA YoY % growth | -49.87M -124.13% | -54.96M -10.21% | -38.739M 29.51% | -68.146M -75.91% | -71.002M -4.19% | -94.758M -33.46% | -99.654M -5.17% | -96.186M 3.48% | -71.604M 25.56% | -29.172M 59.26% | N/A | |
| EBIT YoY % growth | -50.09M -123.62% | -56.06M -11.92% | -40.503M 27.75% | -75.383M -86.12% | -105.138M -39.47% | -121.574M -15.63% | -109.193M 10.18% | -97.197M 10.99% | -40.132M 58.71% | 68.39M 270.41% | 40.635M -40.58% | |
| Operating Margin | N/A | -341.83% | -203.09% | -3,932.36% | -4,087.79% | -1,191.90% | -1,760.61% | -248.31% | -33.98% | 29.84% | 19.23% | |
| EPS YoY % growth | -88.35 | -1.88 97.87% | -1.04 44.68% | -1.59 -53.33% | -1.88 -18.12% | -1.69 10.22% | -1.57 7.42% | -1.63 -4.23% | -0.98 40.00% | 0.49 150.52% | 0.64 29.90% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.43 -29.30% | -0.54 -39.27% | -0.57 -41.53% | -0.53 -40.25% | -0.50 -17.13% | -0.32 41.22% | -0.34 39.64% | -0.37 30.91% | -0.40 20.82% | -0.44 -38.02% | -0.43 -25.67% | -0.49 -33.24% |
| Revenue Q2Q % growth | 307.703K -79.50% | 382.5K -48.45% | 382.5K -66.54% | 382.5K | 382.5K 24.31% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -17.524M -56.49% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -20.77M -60.24% | -17.589M -2.49% | -18.163M 4.21% | -19.809M -15.68% | -20.192M 2.78% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.38 -65.22% | -0.42 | 0.04 | 9.61% |
| Q2 2024 Q2Q % growth | -0.40 -185.71% | -0.38 | -0.02 | -4.30% |
| Q1 2024 Q2Q % growth | -0.39 -14.71% | -0.36 | -0.03 | -9.56% |
| Q4 2023 Q2Q % growth | -0.33 15.38% | -0.44 | 0.11 | 25.39% |
| Q3 2023 Q2Q % growth | -0.23 42.50% | -0.40 | 0.17 | 42.88% |
| Q2 2023 Q2Q % growth | -0.14 73.58% | -0.43 | 0.29 | 67.48% |
| Q1 2023 Q2Q % growth | -0.34 39.29% | -0.51 | 0.17 | 33.33% |
| Q4 2022 Q2Q % growth | -0.39 40.91% | -0.56 | 0.17 | 29.97% |
| Q3 2022 Q2Q % growth | -0.40 21.57% | -0.61 | 0.21 | 34.91% |
| Q2 2022 Q2Q % growth | -0.53 86.13% | -0.44 | -0.09 | -21.55% |
| Q1 2022 Q2Q % growth | -0.56 99.33% | -0.63 | 0.07 | 10.73% |
| Q4 2021 Q2Q % growth | -0.66 | -0.54 | -0.12 | -22.09% |
| Q3 2021 Q2Q % growth | -0.51 | -0.45 | -0.06 | -12.36% |
| Q2 2021 Q2Q % growth | -3.82 | -0.37 | -3.45 | -921.38% |
| Q1 2021 Q2Q % growth | -83.36 | -0.47 | -82.89 | -17,666.41% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -100.00% | 724.2K | -724.2K | -100.00% |
| Q2 2024 Q2Q % growth | 1.143M -85.86% | 858.84K | 284.16K | 33.09% |
| Q1 2024 Q2Q % growth | 742K -83.38% | 1.859M | -1.117M | -60.09% |
| Q4 2023 Q2Q % growth | 1.501M -79.38% | 1.983M | -482K | -24.31% |
| Q3 2023 Q2Q % growth | 5.897M 18.65% | 1.624M | 4.273M | 263.12% |
| Q2 2023 Q2Q % growth | 8.081M 94.72% | 2.512M | 5.569M | 221.70% |
| Q1 2023 Q2Q % growth | 4.464M | 5.1M | -636K | -12.47% |
| Q4 2022 Q2Q % growth | 7.28M | 2.114M | 5.166M | 244.37% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -15.56% | 0% | 5.07% |
| Revenue | 0% | -73.45% | 0% | -45.31% |